NPS Media Releases – CV Risk in Patients With Type 2 Diabetes and CVD – Getting to the Heart of Diabetes

Free webinar
Thursday, 18 October 2018
7:00 – 8:00 pm AEDT

A holistic approach to reducing CV risk in patients with type 2 diabetes & CVD
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality for people with diabetes and the largest contributor to the direct and indirect costs of diabetes. Approximately 65% of all CVD deaths in Australia occur in people with diabetes or prediabetes.

About the webinar
Join our webinar for a multidisciplinary discussion on the prevention of CV events in patients with both type 2 diabetes and CVD. Discussion will cover:

	▷	Evidence-based strategies to reduce CV risk for patients with diabetes and CVD
	▷	Advice on how to individualise choice of blood glucose-lowering agents
	▷	The latest Australian blood glucose treatment algorithm for type 2 diabetes
	▷	An update on the latest CV outcome trial data and how this impacts your practice